User profiles for James P. Sluka

James Sluka

Indiana University, Bloomington, IN USA
Verified email at inpharmix.com
Cited by 2606

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

…, T Seng, TM Suter, JP Sluka… - Journal of Diabetes …, 2000 - hindawi.com
We have screened a subtracted cDNA library in order to identify differentially expressed
genes in omental adipose tissue of human patients with Type 2 diabetes. One clone (#1738) …

Molecular determinants of tissue selectivity in estrogen receptor modulators

TA Grese, JP Sluka, HU Bryant… - Proceedings of the …, 1997 - National Acad Sciences
Interaction of the estrogen receptor/ligand complex with a DNA estrogen response element
is known to regulate gene transcription. In turn, specific conformations of the receptor-ligand …

Using digital twins in viral infection

R Laubenbacher, JP Sluka, JA Glazier - Science, 2021 - science.org
When the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic emerged
in 2019, researchers rapidly recalibrated epidemiological computer models originally …

[HTML][HTML] The 2019 mathematical oncology roadmap

…, KR Swanson, JP Sluka, JA Glazier, P Macklin… - Physical …, 2019 - iopscience.iop.org
… For Mathematical Oncology to achieve its highest impact, Sluka et al argue that standards
are needed for both data and mathematical models, to ensure interoperability, to leverage and …

Toxicokinetic triage for environmental chemicals

…, C Strope, R Goldsmith, JP Sluka… - Toxicological …, 2015 - academic.oup.com
Toxicokinetic (TK) models link administered doses to plasma, blood, and tissue concentrations.
High-throughput TK (HTTK) performs in vitro to in vivo extrapolation to predict TK from …

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators

TA Grese, LD Pennington, JP Sluka… - Journal of medicinal …, 1998 - ACS Publications
The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM)
which is currently under clinical evaluation for the prevention and treatment of …

Learning everywhere: Pervasive machine learning for effective high-performance computation

…, V Jadhao, M Kim, J Qiu, JP Sluka… - 2019 IEEE …, 2019 - ieeexplore.ieee.org
The convergence of HPC and data intensive methodologies provide a promising approach
to major performance improvements. This paper provides a general description of the …

[HTML][HTML] A liver-centric multiscale modeling framework for xenobiotics

JP Sluka, X Fu, M Swat, JM Belmonte, A Cosmanescu… - PloS one, 2016 - journals.plos.org
We describe a multi-scale, liver-centric in silico modeling framework for acetaminophen
pharmacology and metabolism. We focus on a computational model to characterize whole body …

Multiscale modeling in the clinic: drug design and development

…, P Ortoleva, AS Popel, JP Sluka, J Su, P Vicini… - Annals of biomedical …, 2016 - Springer
A wide range of length and time scales are relevant to pharmacology, especially in drug
development, drug design and drug delivery. Therefore, multiscale computational modeling and …

Synthesis of a sequence-specific DNA-cleaving peptide

JP Sluka, SJ Horvath, MF Bruist, MI Simon, PB Dervan - Science, 1987 - science.org
A synthetic 52-residue peptide based on the sequence-specific DNA-binding domain of Hin
recombinase (139-190) has been equipped with ethylenediaminetetraacetic acid (EDTA) at …